Novo Nordisk (NVO) said Monday it will now allow cash-paying patients access to Wegovy injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg at local pharmacies for a reduced cost of $499 per month following updates to its Wegovy savings program.
The $499-per-month offer for Wegovy was only available via the recently launched NovoCare Pharmacy, the company said.
Price: 75.29, Change: -1.57, Percent Change: -2.04
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.